The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice

Wu, Sixian, Li, Xiaoliang, Shang, Lijun, Wu, Lvying, Li, Tongtong, Li, Peiyv, Ji, Zhiliang, Hou, Jianwen, Yin, Mingzhu and Xu, Wenming (2022) The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice. Acta Biochimica et Biophysica Sinica, 54 (10). pp. 1-12. ISSN 1745-7270

Abstract

Small molecule inhibitors of the bromodomain and extraterminal domain (BET) family proteins have emerged as a promising option for not only the treatment of multiple cancers but also for disturbing the process of sperm maturation with potential for use as a viable contraceptive target. In this paper, we report a new generation of BET family inhibitor, NHWD870, that provide a complete and reversible contraceptive effect in mice which is stronger than that of JQ1 and its synthesized derivatives. This study is hoped to lead to the clinical trial eventually.

Documents
7922:41258
[thumbnail of 8003398BAEB442668F2951279601F3DD (3).pdf]
Preview
8003398BAEB442668F2951279601F3DD (3).pdf - Published Version

Download (5MB) | Preview
Details
Record
View Item View Item